We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.68B
AUM Growth
+$43.8M
Cap. Flow
-$77.1M
Cap. Flow %
-2.88%
Top 10 Hldgs %
33.94%
Holding
121
New
7
Increased
28
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
2
CORT icon
Corcept Therapeutics
CORT
+$15.5M
3
GTLS
Chart Industries
GTLS
+$14M
4
TGTX icon
TG Therapeutics
TGTX
+$12.7M
5
EHC icon
Encompass Health
EHC
+$10.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.9M
2
APP icon
Applovin
APP
+$23.4M
3
UBER icon
Uber
UBER
+$22.7M
4
IQV icon
IQVIA
IQV
+$11.8M
5
VRT icon
Vertiv
VRT
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 29.33%
2 Financials 13.75%
3 Communication Services 12.62%
4 Consumer Discretionary 10.61%
5 Healthcare 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
51
Procter & Gamble
PG
$339B
$21.1M 0.79%
125,973
+932
+0.7% +$159K
HD icon
52
Home Depot
HD
$355B
$20.8M 0.78%
53,490
+1,264
+2% +$516K
UNH icon
53
UnitedHealth
UNH
$370B
$20.7M 0.77%
40,983
-4,958
-11% -$2.82M
BMY icon
54
Bristol-Myers Squibb
BMY
$132B
$19.7M 0.74%
+348,518
New +$19.5M
DHR icon
55
Danaher
DHR
$144B
$19.4M 0.73%
84,616
-1,391
-2% -$342K
MU icon
56
Micron Technology
MU
$991B
$19.2M 0.72%
228,716
-10,251
-4% -$1.04M
VICI icon
57
VICI Properties
VICI
$29.4B
$19.2M 0.72%
658,269
-9,380
-1% -$296K
KO icon
58
Coca-Cola
KO
$375B
$19.2M 0.72%
308,500
-4,940
-2% -$322K
LTH icon
59
Life Time Group Holdings
LTH
$9.79B
$19.2M 0.72%
867,132
+17,340
+2% +$415K
MMM icon
60
3M
MMM
$94.3B
$18.4M 0.69%
142,596
+22,203
+18% +$2.91M
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$126B
$18.3M 0.68%
45,450
-6,047
-12% -$2.8M
ONTO icon
62
Onto Innovation
ONTO
$15.3B
$18.2M 0.68%
109,136
-1,431
-1% -$261K
COP icon
63
ConocoPhillips
COP
$141B
$17.5M 0.65%
176,723
+156
+0.1% +$16.6K
TECK icon
64
Teck Resources
TECK
$32.6B
$17.4M 0.65%
429,364
-1,139
-0.3% -$53.2K
GEHC icon
65
GE HealthCare
GEHC
$32.4B
$17.3M 0.65%
221,509
+900
+0.4% +$76.5K
AEE icon
66
Ameren
AEE
$30.1B
$17.2M 0.64%
192,429
-1,533
-0.8% -$137K
ETN icon
67
Eaton
ETN
$174B
$16.8M 0.63%
50,714
-389
-0.8% -$137K
GTLS
68
DELISTED
Chart Industries
GTLS
$16.6M 0.62%
+87,148
New +$14M
SN icon
69
SharkNinja
SN
$26.1B
$16.4M 0.61%
168,880
+84,554
+100% +$8.63M
VOO icon
70
Vanguard S&P 500 ETF
VOO
$1.03T
$15.6M 0.58%
28,991
-988
-3% -$535K
REGN icon
71
Regeneron Pharmaceuticals
REGN
$80.8B
$15.3M 0.57%
21,492
-654
-3% -$549K
CORT icon
72
Corcept Therapeutics
CORT
$12B
$14.9M 0.56%
+296,390
New +$15.5M
NUE icon
73
Nucor
NUE
$62.1B
$14.7M 0.55%
125,945
-1,111
-0.9% -$160K
TGTX icon
74
TG Therapeutics
TGTX
$7.62B
$13.3M 0.5%
+442,805
New +$12.7M
TMO icon
75
Thermo Fisher Scientific
TMO
$220B
$12.8M 0.48%
24,657
-276
-1% -$152K
1 2
3
4 5

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return

Braun Stacey Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Braun Stacey Associates held 121 positions worth $2.68B, up 1.7% from $2.63B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q4 2024 filing shows 7 new, 28 increased, 73 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 348,518 shares worth $19.7M. The largest sale was Merck, an estimated $24.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q4 2024 buy was Bristol-Myers Squibb: 348,518 shares worth $19.7M.
  • Braun Stacey Associates added most to Targa Resources in Q4 2024, an estimated $10.2M increase.
  • Braun Stacey Associates's biggest Q4 2024 reduction was Applovin, cutting an estimated $23.4M.
  • Braun Stacey Associates fully exited Merck in Q4 2024, selling an estimated $24.9M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.68B portfolio in Q4 2024.
  • Braun Stacey Associates opened 7 new positions and closed 5 in Q4 2024.
  • Braun Stacey Associates's portfolio value rose 1.7% quarter-over-quarter to $2.68B.

Based on Braun Stacey Associates's 13F filing for Q4 2024, filed 31 Jan 2025.